Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: Safety and efficacy

Stem Cells and Development

Volumn 22, Issue 24, 2013, Pages 3192-3202

  Wang, Liming ^a   Wang, Lihua ^b   Cong, Xiuli ^c   Liu, Guangyang ^c   Zhou, Jianjun ^a   Bai, Bin ^a   Li, Yang ^a   Bai, Wen ^a   Li, Ming ^a   Ji, Haijie ^c   Zhu, Delin ^c   Wu, Mingyuan ^d,e   Liu, Yongjun ^c,e  

^a Chinese People s Liberation Army 323 Hospital   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c Zhongyuan Union Stem Cell Bioengineering Co Ltd   (China)

^d UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^e TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; CD4 ANTIGEN; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 6; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; RANTES; STEROID; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD ANALYSIS; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHILL; COHORT ANALYSIS; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DAS28; DISEASE ACTIVITY; FEMALE; FEVER; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION; RHEUMATOID ARTHRITIS; SEROLOGY; STEROID THERAPY; THERAPY EFFECT; TREATMENT RESPONSE;

ADULT; ARTHRITIS, RHEUMATOID; CELL- AND TISSUE-BASED THERAPY; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; INTERLEUKIN-6; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; QUESTIONNAIRES; SAFETY; T-LYMPHOCYTES, REGULATORY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD;

EID: 84889675964     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0023     Document Type: Article

References (42)

1. McInnes IB and G Schett. (2011). The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205-2219
2. Sakaguchi S, T Yamaguchi, T Nomura and M Ono. (2008). Regulatory T cells and immune tolerance. Cell 133:775-787
3. van Amelsfort JM, KM Jacobs, JW Bijlsma, FP Lafeber and LS Taams. (2004). CD4 (+) CD25 (+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775-2785
4. Feldmann M. (2002). Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2:364-371
5. Moreland LW, MH Schiff, SW Baumgartner, EA Tindall, RM Fleischmann, KJ Bulpitt, AL Weaver, EC Keystone, DE Furst, et al. (1999). Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann Intern Med 130:478-486
6. Moreland LW, SW Baumgartner, MH Schiff, EA Tindall, RM Fleischmann, AL Weaver, RE Ettlinger, S Cohen, WJ Koopman, et al. (1997). Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337:141-147
7. Cohen S, E Hurd, J Cush, M Schiff, ME Weinblatt, LW Moreland, J Kremer, MB Bear, WJ Rich and D McCabe. (2002). Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 46:614-624
8. Bresnihan B and G Cunnane. (2003). Infection complications associated with the use of biologic agents. Rheum Dis Clin North Am 29:185-202
9. Campagnoli C, IA Roberts, S Kumar, PR Bennett, I Bellantuono and NM Fisk. (2001). Identification of mesenchymal stem/progenitor cells in human first-Trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402
10. Zuk PA, M Zhu, H Mizuno, J Huang, JW Futrell, AJ Katz, P Benhaim, HP Lorenz and MH Hedrick. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228
11. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147
12. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736
13. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441
14. Sun L, K Akiyama, H Zhang, T Yamaza, Y Hou, S Zhao, T Xu, A Le and S Shi. (2009). Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421-1432
15. Mohanty ST, L Kottam, A Gambardella, MJ Nicklin, L Coulton, D Hughes, AG Wilson, PI Croucher and I Bellantuono. (2010). Alterations in the self-renewal and differentiation ability of bone marrow mesenchymal stem cells in a mouse model of rheumatoid arthritis. Arthritis Res Ther 12:R149
16. Gonzalez MA, E Gonzalez-Rey, L Rico, D Buscher and M Delgado. (2009). Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells. Arthritis Rheum 60:1006-1019
17. Augello A, R Tasso, SM Negrini, R Cancedda and G Pennesi. (2007). Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 56:1175-1186
18. Arnett FC, SM Edworthy, DA Bloch, DJ McShane, JF Fries, NS Cooper, LA Healey, SR Kaplan, MH Liang, HS Luthra, et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
19. Lu LL, YJ Liu, SG Yang, QJ Zhao, X Wang, W Gong, ZB Han, ZS Xu, YX Lu, et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026
20. Horwitz EM, K Le Blanc, M Dominici, I Mueller, I Slaper-Cortenbach, FC Marini, RJ Deans, DS Krause and A Keating. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7:393-395
21. Glasser L, RL Fiederlein and DW Huestis. (1985). Liquid preservation of human neutrophils stored in synthetic media at 22 degrees C: Controlled observations on storage variables. Blood 66:267-272
22. van Gestel AM, CJ Haagsma and PL van Riel. (1998). Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 41:1845-1850
23. Pincus T, C Swearingen and F Wolfe. (1999). Toward a multidimensional Health Assessment Questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220-2230
24. Scott DL, JS Smolen, JR Kalden, LB van de Putte, A Larsen, TK Kvien, M Schattenkirchner, P Nash, C Oed and I Loew-Friedrich. (2001). Treatment of active rheumatoid arthritis with leflunomide: Two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis 60:913-923
25. Saklatvala J. (1986). Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 322:547-549
26. Buchan G, K Barrett, T Fujita, T Taniguchi, R Maini and M Feldmann. (1988). Detection of activated T cell products in the rheumatoid joint using cDNA probes to interleukin-2 (IL-2) IL-2 receptor and IFN-gamma. Clin Exp Immunol 71:295-301
27. Hirano T, T Matsuda, M Turner, N Miyasaka, G Buchan, B Tang, K Sato, M Shimizu, R Maini, M Feldmann, et al. (1988). Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:1797-1801
28. Brennan FM and IB McInnes. (2008). Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 118:3537-3545
29. Maini R, EW St Clair, F Breedveld, D Furst, J Kalden, M Weisman, J Smolen, P Emery, G Harriman, M Feldmann and P Lipsky. (1999). Infliximab (chimeric anti-Tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group. Lancet 354:1932-1939
30. Giles JT, SJ Bartlett, AC Gelber, S Nanda, K Fontaine, V Ruffing and JM Bathon. (2006). Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 55:333-337
31. Liu Y, R Mu, S Wang, L Long, X Liu, R Li, J Sun, J Guo, X Zhang, et al. (2010). Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res Ther 12:R210
32. Kastrinaki MC, P Sidiropoulos, S Roche, J Ringe, S Lehmann, H Kritikos, VM Vlahava, B Delorme, GD Eliopoulos, et al. (2008). Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 67:741-749
33. Le Blanc K, F Frassoni, L Ball, F Locatelli, H Roelofs, I Lewis, E Lanino, B Sundberg, ME Bernardo, et al. (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586
34. Badiavas EV, M Abedi, J Butmarc, V Falanga and P Quesenberry. (2003). Participation of bone marrow derived cells in cutaneous wound healing. J Cell Physiol 196:245-250
35. Sasaki M, R Abe, Y Fujita, S Ando, D Inokuma and H Shimizu. (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol 180:2581-2587
36. Ji KH, J Xiong, LX Fan, KM Hu and HQ Liu. (2009). Rat marrow-derived multipotent adult progenitor cells differentiate into skin epidermal cells in vivo. J Dermatol 36:403-409
37. Yeum CE, EY Park, SB Lee, HJ Chun and GT Chae. (2013). Quantification of MSCs involved in wound healing: Use of SIS to transfer MSCs to wound site and quantification of MSCs involved in skin wound healing. J Tissue Eng Regen Med 7:279-291
38. de Kleer I, B Vastert, M Klein, G Teklenburg, G Arkesteijn, GP Yung, S Albani, W Kuis, N Wulffraat and B Prakken. (2006). Autologous stem cell transplantation for autoimmunity induces immunologic self-Tolerance by reprogramming autoreactive T cells and restoring the CD4 + CD25 + immune regulatory network. Blood 107:1696-1702
39. Rai S, RS Marak, S Jain and TN Dhole. (2012). Posterior fossa midline cryptococcoma in a patient with idiopathic CD4 lymphocytopenia. Indian J Med Microbiol 30:367-370
40. Ortiz LA, M Dutreil, C Fattman, AC Pandey, G Torres, K Go and DG Phinney. (2007). Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104:11002-11007
41. Wang Q, X Li, J Luo, L Zhang, L Ma, Z Lv and L Xue. (2012). The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system. BMC Musculoskelet Disord 13:249
42. Maumus M, C Jorgensen and D Noel. (2013). Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: Role of secretome and exosomes. Biochimie [Epub ahead of print]; DOI: 10.1016/j.biochi.2013.04.017